Programmable Infusion Pumps and Catheters Market Opportunity Analysis-2027


Posted July 8, 2021 by SANJAYCMI

“Coherent Market Insights “PROGRAMMABLE INFUSION PUMPS AND CATHETERS MARKET – GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027″
 
The global Programmable Infusion Pumps And Catheters Market by Product Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Implantable Pumps, Patient Controlled Analgesia Pumps, and Pump Accessories), by Modality (Portable and Stationary), by Application (Oncology, Pediatrics/Neonatology, Pain, Gastroenterology, Hematology, and Diabetes), by Channel Type (Single Channel and Multi-Channel), by End User (Hospitals, Ambulatory Clinics, Homecare, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 8,365.3 million in 2017, and is projected to exhibit a CAGR of 5.8% over the forecast period (2018–2026), as highlighted in a new report.

New product launches and therapeutic advantages, such as dose monitoring, offered by programmable infusion pumps over manual counterparts are expected to boost the global programmable infusion pumps and catheters market growth. Moreover, key players in the market are focused on launching new products in order to enhance their market share. For instance, in 2018, Baxter International Inc., a company involved in innovative technology for medication delivery, received approval for Spectrum IQ Infusion System with Dose IQ Safety Software from U.S. Food and Drug Administration (FDA). Spectrum IQ system is designed specifically for bi-directional electronic medical records (EMR) integration, along with features that assist appropriate dosing of medications to the patient.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2565

Browse 24 Market Data Tables and 33 Figures spread through 181 Pages and in-depth TOC on global programmable infusion pumps and catheters market, by Product Type (Volumetric Pumps, Syringe Pumps, Enteral Pumps, Insulin Pumps, Implantable Pumps, Patient Controlled Analgesia Pumps, and Pump Accessories), by Modality (Portable and Stationary), by Application (Oncology, Pediatrics/Neonatology, Pain, Gastroenterology, Hematology, and Diabetes), by Channel Type (Single Channel and Multi-Channel), by End User (Hospitals, Ambulatory Clinics, Homecare, Clinics, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2026.

Strategic mergers and acquisitions by key players is expected to support the global programmable infusion pumps and catheters market growth. For instance, in April 2017, BD (Becton, Dickinson and Company), a global medical technology company completed the acquisition of Caesarea Medical Electronics (CME), a global manufacturer of infusion pump systems. This merger resulted in expansion of company’s home care, specialty applications, and ambulatory infusion portfolio.

Browse Research Report: https://www.coherentmarketinsights.com/market-insight/programmable-infusion-pumps-and-catheters-market-2565

Key Takeaways of the global programmable infusion pumps and catheters market:

The global programmable infusion pumps and catheters market is expected to exhibit a CAGR of 8% over the forecast period. This is owing to increasing research and development activities by key players and product launches.

Manufacturers are focused on strategic mergers and acquisitions, as well as raising funds for obtaining product clearance and product commercialization

North America is expected to be dominant in the global programmable infusion pumps and catheters market over the forecast period, owing to product launches and active research and development activities by key players in the region

Major players operating in the global programmable infusion pumps and catheters market include, ICU Medical, Inc., Smiths Group plc., Baxter International Inc., Fresenius Se & Co. KGaA, Johnson & Johnson, Medtronic plc., Becton, Dickinson and Company, Terumo Corporation, B. Braun Melsungen AG, and Moog Inc.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2565

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags programmable infusion pumps and catheters , programmable infusion pumps and catheters market growth , programmable infusion pumps and catheters market research
Last Updated July 8, 2021